Professor Sarah Gilbert (University of Oxford) presenting the 2024 UCL Prize Lecture in Life and Medical Sciences on 'Vaccine development during and after the pandemic.'
About Professor Sarah Gilbert, DBE, FRS, FMedSci
Sarah Gilbert is a Professor of Vaccinology in the Pandemic Sciences Institute at Oxford University. She works on viral vectored vaccine development, with projects on influenza, Nipah, MERS, and Lassa. Working with colleagues on the Old Road Campus in Oxford, she is able to take novel vaccines from design through GMP manufacturing to clinical development, with a particular interest in the rapid transfer of vaccines into GMP manufacturing and first in human trials. She was the Oxford Project Leader for ChAdOx1 nCoV-19, also known as Vaxevria/Covishield, which was estimated to have saved 6.3 million lives in its first year of use.
